-1.2 C
New York
Friday, February 27, 2026

Viking’s obesity drug study results are ‘almost flawless’, says Oppenheimer’s Jay Olson

Jay Olson, Oppenheimer biotech analyst, joins ‘Fast Money’ to talk Viking’s best trading day ever and the results of its obesity drug study.

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

149,471FansLike
396,312FollowersFollow
2,650SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x